Twelve isolates of Streptococcus pneumoniae with decreased susceptibility by oxacillin screen were susceptible by the FOX panel (Micro Media Systems, Cleveland, Ohio), a commercial microdilution system designed for fastidious organisms. These organisms were found to be moderately susceptible or resistant by broth macrodilution and agar dilution methods. This discrepancy indicates that the FOX panel is not reliable for susceptibility testing of S. pneumoniae.
Screening of isolates of Streptococcus pneumoniae for penicillin resistance with a 1-,ug oxacillin disk has been recommended for many years (6) . This procedure, however, does not distinguish between relatively resistant (MICs, 0.12 to 1.0 ,ug/ml) and resistant (MICs > 1.0 ,ug/ml) pneumococci. The distinction between relatively resistant and resistant pneumococci has clinical importance in the treatment of pneumococcal meningitis and possibly bacteremia. Relatively resistant strains may respond to higher doses of penicillin or other P-lactam antibiotics, whereas vancomycin is recommended for isolates for which penicillin MICs are .2.0 ,ug/ml (2) . When the oxacillin screen indicates decreased susceptibility to penicillin, our policy has been to determine the MIC by using a commercial microdilution system, FOX panel (Micro Media Systems, Cleveland, Ohio).
Recently, we have observed a major discrepancy between the oxacillin screen results and the MIC as determined by the FOX microdilution panel among 12 clinical isolates of pneumococci sent to our laboratory for susceptibility determinations. All 12 isolates were found to be resistant by the oxacillin screen (zone size s 19 mm) but were susceptible by the FOX panel (MIC s 0.06 ,ug/ml).
False susceptibility of S. pneumoniae to penicillin G by using another commercial microdilution system (American Micro Scan, Campbell, Calif.) has been reported by Shanholtzer and Peterson (5). Now we report similar problems with a second commercial microdilution system and compare that system (FOX panel) with the oxacillin screen, broth macrodilution MIC, and agar dilution MIC methods for the determination of S. pneumoniae susceptibility.
All S. pneumoniae strains were fresh clinical isolates submitted to our laboratory for antimicrobial susceptibility testing. Twelve isolates were tested. One was from cerebrospinal fluid and one was from an eye, and the remainder were blood isolates. After evaluation for oxacillin susceptibility and MIC determination with the FOX panel, nine isolates were kept frozen at -70°C and subcultured twice onto Columbia sheep blood agar plates (Remel, Lenexa, Kans.) before use. Freezing and subculturing did not alter results. Three isolates were tested following subculture and 24 h of incubation. Staphylococcus aureus ATCC 29213, for which the penicillin MIC is known (0.25 to 1.0 ,ug/ml), was used as * Corresponding author. a quality control organism for all susceptibility testing. Also included in the evaluation was a known penicillin-susceptible strain of S. pneumoniae (ATCC 6303). All tests were duplicated by two technologists working independently.
A bottle containing 75 ml of Mueller-Hinton agar (BBL, Becton Dickinson, Cockeysville, Md.) was boiled and allowed to cool to 56°C in a water bath. A 3.75-ml sample of sheep erythrocytes (5%) was added to the cooled agar, poured into a petri dish (150 by 15 mm), and allowed to solidify on a level bench top. The plate was then dried in a 35°C ambient-air incubator for 3 h. The plates were inoculated in accordance with the National Committee for Clinical Laboratory Standards (NCCLS) procedure and then incubated aerobically at 33 to 35°C for 18 to 24 h. Zone diameters were measured with a caliper. Interpretation was made according to NCCLS (3) recommendations and those of Swenson et al. (6) .
The MICs for all isolates were determined by three methods, i.e., FOX Fastidious panel, broth tube macrodilution, and agar dilution. All MIC test mixtures were incubated aerobically at 33 to 35°C for a full 24 h. With the exception of the FOX Fastidious MIC panel, interpretation of results followed NCCLS guidelines.
The FOX Fastidious MIC panels were received and kept frozen until used. The panels were inoculated according to the procedure outlined in the package insert. MIC results were read with the aid of a plate viewer (Esteem; Micro Media Systems) and were interpreted according to the FOX Fastidious MIC interpretation guidelines, i.e. s0.06 ,ug/ml, susceptible; 0.12 to 1.0 ,ug/ml, moderately susceptible; and .1.0 ,ug/ml, resistant.
For the macrodilution MIC, lysed horse erythrocytes (LHB) were added to cation-supplemented Mueller-Hinton broth (CSMHB) to achieve a final concentration of 3% as outlined by NCCLS (4). Twofold serial tube dilutions of penicillin G were made in CSMHB-LHB (100 to 0.025 ,ug/ml). A 0.5 McFarland standard was prepared from an overnight growth on a sheep blood agar plate, further diluted to 1:200 in CSMHB-LHB, and then added (0.5 ml) to each tube for a final concentration of approximately 5 X 105 CFU/ml (total volume, 1.0 ml).
For the agar dilution MIC, Mueller-Hinton agar (BBL) was supplemented with 5% sheep blood and penicillin G in concentrations ranging from 0.012 to 0.8 ,ug/ml in doubling dilutions. An antibiotic free plate was used as a growth control. The plates were inoculated with 0.001 ,ul of 1:100 The results in Table 1 represent a summary of the susceptibility test results. All 12 clinical isolates tested were resistant by the oxacillin screen. Zone sizes ranged from 6 to 17 mm. Of the 12 isolates, 11 were found to be susceptible by the FOX panel. Although strain 5 had an MIC of 0.25 ,ug/ml by the FOX panel, this was considerably lower than the broth and agar dilution MICs (2.0 ,ug/ml and 1.0 ,ug/ml, respectively). There was excellent correlation between the oxacillin screen and the broth macrodilution MIC. In contrast, the agar dilution MICs were susceptible for isolates 1 and 9. In addition, upon repeat testing there was more intértechnologist variation with the agar dilution than with the broth macrodilution method for several of the isolates.
It is unclear why the FOX panel yielded results discrepant with those obtained with the oxacillin screen. One explanation may be that these particular strains may be more fastidious than most, although growth in the control wells was good at 24 h for all isolates. The smaller inoculum recommended, 2.6 x 105 CFU/ml, may also be a factor, although Shanholtzer and Peterson did not find this to be a major factor with the Microscan microtiter system (5) . Finally, the undisclosed commercial broth formulation itself may not be supportive of certain strains.
Our results indicate that the FOX Fastidious panel is not an acceptable method for determining susceptibility of S. pneumoniae to penicillin G. In view of our results and previous literature, caution should be used when commercial microtiteffsystems are implemented for testing pneumococcal isolates. A recent multicenter study (1) revealed good reproducibility among several laboratories when a microtiter system with Haemophilus test media was used. However, the authors of that report caution that the breakpoints may néed to be redefined with this system. Until more data regarding microtiter systems are available, we have adopted the following procedure. AHl clinical isolates of S. pneumoniae are screen-ed for decreased susceptibility with the Kirby-Bauer 1-,ug oxacillin disk. Clinically significant isolates with zone sizes of <20 mm are further tested by the broth macrodilution method which, in our laboratory, appears more reliable than the agar dilution MIC method.
